These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35141126)

  • 1. Risk Factor Clusters and Cardiovascular Disease in High-Risk Patients: The UCC-SMART Study.
    Holthuis EI; Visseren FLJ; Bots ML; Peters SAE;
    Glob Heart; 2021; 16(1):85. PubMed ID: 35141126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clustering of risk factors and the risk of incident cardiovascular disease in Asian and Caucasian populations: results from the Asia Pacific Cohort Studies Collaboration.
    Peters SAE; Wang X; Lam TH; Kim HC; Ho S; Ninomiya T; Knuiman M; Vaartjes I; Bots ML; Woodward M;
    BMJ Open; 2018 Mar; 8(3):e019335. PubMed ID: 29511013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy.
    Joseph P; Kutty VR; Mohan V; Kumar R; Mony P; Vijayakumar K; Islam S; Iqbal R; Kazmi K; Rahman O; Yusuf R; Anjana RM; Mohan I; Rangarajan S; Gupta R; Yusuf S
    Eur Heart J; 2022 Aug; 43(30):2831-2840. PubMed ID: 35731159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in population attributable fraction of modifiable risk factors for cardiovascular diseases across three decades.
    Zhu F; Boersma E; Tilly M; Ikram MK; Qi H; Kavousi M
    Eur J Prev Cardiol; 2024 Oct; 31(14):1724-1733. PubMed ID: 38935527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study.
    Sardarinia M; Akbarpour S; Lotfaliany M; Bagherzadeh-Khiabani F; Bozorgmanesh M; Sheikholeslami F; Azizi F; Hadaegh F
    PLoS One; 2016; 11(12):e0167623. PubMed ID: 27930696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of chronic kidney disease and diabetes on cardiovascular mortality in a general Japanese population: A 20-year follow-up of the NIPPON DATA90 study.
    Hirata A; Okamura T; Sugiyama D; Kuwabara K; Kadota A; Fujiyoshi A; Miura K; Okuda N; Ohkubo T; Okayama A; Ueshima H;
    Eur J Prev Cardiol; 2017 Mar; 24(5):505-513. PubMed ID: 27856810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort profile: the Utrecht Cardiovascular Cohort-Second Manifestations of Arterial Disease (UCC-SMART) Study-an ongoing prospective cohort study of patients at high cardiovascular risk in the Netherlands.
    Castelijns MC; Helmink MAG; Hageman SHJ; Asselbergs FW; de Borst GJ; Bots ML; Cramer MJ; Dorresteijn JAN; Emmelot-Vonk MH; Geerlings MI; de Jong PA; van der Kaaij NP; Kappelle LJ; Lely AT; van der Meer MG; Mol BM; Nathoe HM; Onland-Moret NC; van Petersen RB; Ruigrok YM; van Smeden M; Teraa M; Vandersteen A; Verhaar MC; Westerink J; Visseren FLJ
    BMJ Open; 2023 Feb; 13(2):e066952. PubMed ID: 36806141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk assessment of dyslipidemic middle-aged adults without overt cardiovascular disease over the period of 2009-2016 in Lithuania.
    Kutkiene S; Petrulioniene Z; Laucevicius A; Serpytis P; Kasiulevicius V; Staigyte J; Saulyte A; Petrulionyte E; Gargalskaite U; Skiauteryte E; Matuzeviciene G; Kovaite M; Rinkuniene E
    Lipids Health Dis; 2018 Oct; 17(1):233. PubMed ID: 30305084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and associated risk factors for premature death in the Tehran Lipid and Glucose Study cohort, Iran.
    Eslami A; Naghibi Irvani SS; Ramezankhani A; Fekri N; Asadi K; Azizi F; Hadaegh F
    BMC Public Health; 2019 Jun; 19(1):719. PubMed ID: 31182076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between prehypertension and clustering of cardiovascular disease risk factors among Chinese adults.
    Yu D; Huang J; Hu D; Chen J; Cao J; Li J; Gu D
    J Cardiovasc Pharmacol; 2009 May; 53(5):388-400. PubMed ID: 19454899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in prevalence of dyslipidaemias and the risk of mortality in Lithuanian urban population aged 45-64 in relation to the presence of the dyslipidaemias and the other cardiovascular risk factors.
    Luksiene D; Tamosiunas A; Baceviciene M; Radisauskas R; Malinauskiene V; Peasey A; Bobak M
    PLoS One; 2014; 9(6):e100158. PubMed ID: 24955583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease and all-cause mortality associated with individual and combined cardiometabolic risk factors.
    Cao X; Zhang L; Wang X; Chen Z; Zheng C; Chen L; Zhou H; Cai J; Hu Z; Tian Y; Gu R; Huang Y; Wang Z
    BMC Public Health; 2023 Sep; 23(1):1725. PubMed ID: 37670287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiable risk factors associated with cardiovascular disease and mortality in China: a PURE substudy.
    Li S; Liu Z; Joseph P; Hu B; Yin L; Tse LA; Rangarajan S; Wang C; Wang Y; Islam S; Liu W; Lu F; Li Y; Hou Y; Qiang D; Zhao Q; Li N; Lei R; Chen D; Han A; Liu G; Zhang P; Zhi Y; Liu C; Yang J; Resalaiti A; Ma H; Ma Y; Liu Y; Xing X; Xiang Q; Liu Z; Sheng Y; Tang J; Liu L; Yusuf S; Li W
    Eur Heart J; 2022 Aug; 43(30):2852-2863. PubMed ID: 35731140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy.
    Lopez-Jaramillo P; Joseph P; Lopez-Lopez JP; Lanas F; Avezum A; Diaz R; Camacho PA; Seron P; Oliveira G; Orlandini A; Rangarajan S; Islam S; Yusuf S
    Eur Heart J; 2022 Aug; 43(30):2841-2851. PubMed ID: 35325078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustering of cardiovascular disease biological risk factors among older adults in Shenzhen City, China: a cross-sectional study.
    Ni W; Weng R; Yuan X; Lv D; Song J; Chi H; Liu H; Xu J
    BMJ Open; 2019 Mar; 9(3):e024336. PubMed ID: 30850407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study.
    Lee J; Ma S; Heng D; Chew S; Hughes K; Tai E
    J Hum Hypertens; 2008 Jul; 22(7):468-74. PubMed ID: 18337755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Disease Risk Factor Control in People With and Without HIV.
    Silverberg MJ; Levine TM; Lea AN; Williams AE; Alexeeff SE; Bryant K; Cavassini M; Flamm JA; Hare CB; Ingle SM; Justice AC; Lam JO; Sterling SA; Horberg MA; Satre DD
    Clin Infect Dis; 2024 May; 78(5):1264-1271. PubMed ID: 38227614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranking age-specific modifiable risk factors for cardiovascular disease and mortality: evidence from a population-based longitudinal study.
    Tian F; Chen L; Qian ZM; Xia H; Zhang Z; Zhang J; Wang C; Vaughn MG; Tabet M; Lin H
    EClinicalMedicine; 2023 Oct; 64():102230. PubMed ID: 37936651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attributable fractions of risk factors for cardiovascular diseases.
    Hozawa A
    J Epidemiol; 2011; 21(2):81-6. PubMed ID: 21293069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality.
    Haring R; John U; Völzke H; Nauck M; Dörr M; Felix SB; Wallaschofski H
    Gend Med; 2012 Dec; 9(6):557-68. PubMed ID: 23182129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.